The objectives of this proposed research are to design and synthesize sulfur containing compounds that stimulate detoxifying enzymes as defenses against carcinogens. The long-term goal is to develop these compounds into cancer chemopreventive agents for human use. To test the activity of the new compounds as potential inhibitors of chemically induce carcinogenesis, a number of rapid screening tests and in vivo tumor inhibition experiments will be carried out. The inhibition of DNA methylation of DNA in the lung and the precancerous lesions in the colon of mice will be determined. The inhibition of lung and colon tumorigenesis in mice by these new compounds will be determined. The results will indicate whether the new compounds may be used as chemopreventive agents in the lung and colon, respectively.

Proposed Commercial Applications

The sulfur containing compounds may be developed into cancer chemopreventive agents for human use.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44CA062707-03
Application #
2414300
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (02))
Program Officer
Crowell, James A
Project Start
1994-08-01
Project End
1999-12-31
Budget Start
1997-05-07
Budget End
1999-12-31
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Lkt Laboratories, Inc.
Department
Type
DUNS #
City
St. Paul
State
MN
Country
United States
Zip Code
55114